Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

Oxular Ltd.

Founded in 2014, Precision Ocular is developing novel retinal treatments engineered to access specific small spaces in the eye and to provide unique drug distribution to tissues specifically involved in retinal diseases. The unique approach aims to increase therapeutic effectiveness, reduce side-effects and minimise frequency of treatments. Precision's product development pipeline includes treatments for both prevalent retinal diseases, such as age related macular degeneration and diabetic macular oedema, as well as rare and orphan indications. *


Period Start 2014-01-01 established pred
  Predecessor Precision Ocular Ltd.
Products Industry ophthalmic
  Industry 2 drug delivery technology (drug formulation technology)
Person Person Cavanagh, Thomas (Tom) (Precision Ocular 201607 CEO)
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  City n. a. 
    Address record changed: 2016-12-04
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2021-03-08


Picture [iito] Plain Stupid Simple 650x80px

More documents for Oxular Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top